Viewing StudyNCT03920007



Ignite Creation Date: 2024-05-06 @ 1:05 PM
Last Modification Date: 2024-10-26 @ 1:08 PM
Study NCT ID: NCT03920007
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-02-20
First Post: 2019-04-10

Brief Title: Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D
Sponsor: Atsena Therapeutics Inc
Organization: Atsena Therapeutics Inc

Conditions & Keywords Data

Conditions:
Name
Leber Congenital Amaurosis
LCA
LCA1
Keywords:
Name View
GUCY2D View